Burleson & Company, LLC Abbott Laboratories Transaction History
Burleson & Company, LLC
- $384 Million
- Q4 2022
A detailed history of Burleson & Company, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Burleson & Company, LLC holds 12,569 shares of ABT stock, worth $1.49 Million. This represents 0.36% of its overall portfolio holdings.
Number of Shares
12,569
Previous 12,569
-0.0%
Holding current value
$1.49 Million
Previous $1.22 Million
13.49%
% of portfolio
0.36%
Previous 0.26%
Shares
11 transactions
Others Institutions Holding ABT
# of Institutions
3,167Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.19M-
Vanguard Group Inc Valley Forge, PA166MShares$19.7 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$15.6 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.82 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.52 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.79 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $208B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...